LifeMD/$LFMD
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Ticker
$LFMD
Sector
Primary listing
Employees
306
Headquarters
Website
LifeMD Metrics
BasicAdvanced
$191M
-
-$0.25
1.33
-
Price and volume
Market cap
$191M
Beta
1.33
52-week high
$15.84
52-week low
$3.43
Average daily volume
1.2M
Financial strength
Current ratio
0.725
Quick ratio
0.583
Long term debt to equity
173.735
Total debt to equity
193.731
Interest coverage (TTM)
-1.46%
Profitability
EBITDA (TTM)
-1.362
Gross margin (TTM)
86.84%
Net profit margin (TTM)
-3.21%
Operating margin (TTM)
-1.26%
Effective tax rate (TTM)
-5.23%
Revenue per employee (TTM)
$820,000
Management effectiveness
Return on assets (TTM)
-2.85%
Return on equity (TTM)
527.14%
Valuation
Price to revenue (TTM)
0.719
Price to book
144.98
Price to tangible book (TTM)
-12.36
Price to free cash flow (TTM)
-53.632
Free cash flow yield (TTM)
-1.86%
Free cash flow per share (TTM)
-0.076
Growth
Revenue change (TTM)
29.54%
Earnings per share change (TTM)
-61.04%
3-year revenue growth (CAGR)
28.33%
10-year revenue growth (CAGR)
73.61%
3-year earnings per share growth (CAGR)
-47.91%
10-year earnings per share growth (CAGR)
24.81%
What the Analysts think about LifeMD
Analyst ratings (Buy, Hold, Sell) for LifeMD stock.
LifeMD Financial Performance
Revenues and expenses
LifeMD Earnings Performance
Company profitability
LifeMD News
AllArticlesVideos
LifeMD Stock Plummets After Q3 Earnings: Here's Why
Benzinga2 days ago
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Business Wire3 weeks ago
LFMD FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of LifeMD Upcoming Lead Plaintiff Deadline on Monday, October 27, 2025
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LifeMD stock?
LifeMD (LFMD) has a market cap of $191M as of November 19, 2025.
What is the P/E ratio for LifeMD stock?
The price to earnings (P/E) ratio for LifeMD (LFMD) stock is 0 as of November 19, 2025.
Does LifeMD stock pay dividends?
No, LifeMD (LFMD) stock does not pay dividends to its shareholders as of November 19, 2025.
When is the next LifeMD dividend payment date?
LifeMD (LFMD) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeMD?
LifeMD (LFMD) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.